Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:BioReference_Laboratories
gptkb:Prolor_Biotech |
| gptkbp:CEO |
gptkb:Phillip_Frost
|
| gptkbp:clinicalTrials |
Chronic diseases
Various ongoing studies Phase 3 trials Rare diseases Phase 1 trials Phase 2 trials |
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:employees |
Over 500
|
| gptkbp:facilities |
gptkb:Israel
gptkb:New_Jersey gptkb:Miami |
| gptkbp:focus |
Biopharmaceuticals
|
| gptkbp:focus_area |
Diagnostics
Therapeutics |
| gptkbp:founded |
2013
|
| gptkbp:founder |
gptkb:Phillip_Frost
|
| gptkbp:headquarters |
gptkb:Miami,_Florida
|
| https://www.w3.org/2000/01/rdf-schema#label |
OPKO Biologics
|
| gptkbp:investmentFocus |
Research and development
|
| gptkbp:market |
Global
|
| gptkbp:partnerships |
gptkb:Eli_Lilly
gptkb:Pfizer gptkb:Teva_Pharmaceuticals Various pharmaceutical companies |
| gptkbp:products |
Diagnostic tests
Therapeutics |
| gptkbp:regulatoryCompliance |
FDA_approvals
|
| gptkbp:research_areas |
Gastroenterology
Immunology Oncology Pain management Psychiatry Pulmonology Transplantation Urology Women's health Neurology Ophthalmology Cardiovascular diseases Infectious diseases Pediatrics Rheumatology Endocrinology Hematology Orthopedics Dermatology Geriatrics Metabolic disorders Men's health |
| gptkbp:sells |
gptkb:NASDAQ
|
| gptkbp:stockExchange |
OPK
|
| gptkbp:subsidiary |
gptkb:OPKO_Health
|
| gptkbp:website |
www.opkobiologics.com
|